Healthcare-focused middle market private equity firm Ampersand Capital Partners has added three new members to its management team. “Ampersand has been making successful middle-market healthcare investments for twenty years, and these key additions further build on our strong base of healthcare investment experience and operating talent,” said Herb Hooper, Ampersand Managing Partner.
Eric Lev has joined Ampersand as a Partner, bringing over 12 years of middle market healthcare investing experience. He was most recently at Water Street Healthcare Partners where he served on the investment team since Water Street’s formation in 2005. While at Water Street he played a key role in helping to build the firm’s practices in life sciences and diagnostics. Prior to Water Street, Mr. Lev worked at Beckman Coulter and at One Equity Partners. He holds a BA from Northwestern University and a MBA from the University of Chicago.
Dana Niles has joined Ampersand as the firm’s CFO and Chief Compliance Officer. Prior to Ampersand, he served as CFO of HighPoint Capital, a senior debt platform acquired by Crescent Capital in 2012. Before HighPoint, Mr. Niles served as Controller at both HLM Venture Partners and YankeeTek Ventures and as a Senior Auditor at Arthur Andersen. He holds a BS in Business Administration from the University of Vermont and is a CPA.
John Perkins has joined Ampersand as an Operating Partner, where he will work with the investment team to identify and evaluate new platform opportunities. Most recently, he served as a senior executive at Ampersand portfolio company Talecris Biotherapeutics, which was acquired by Grifols in 2011. Prior to Talecris, Mr. Perkins held roles as an operating executive at Cerberus and as an executive at General Electric. He has a BA from DePauw University and a MBA from the Kellogg School of Management.
Ampersand Capital Partners makes middle market growth equity investments in the healthcare sector. Over the past twenty years, Ampersand has raised seven funds and invested in more than forty private healthcare companies. These activities have produced a 25% net pooled internal rate of return to the firm’s limited partners. Ampersand is based in Wellesley, MA (www.ampersandcapital.com).
© 2013 PEPD • Private Equity’s Leading News Magazine • 2-26-13
